Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05618834 · ClinicalTrials.gov registry record · NA
Promoting Positive Care Interactions (PPCI) in Assisted Living
A NA study of Alzheimer Disease and Related Dementias, sponsored by Penn State University.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05618834: Active NA study of Alzheimer Disease and Related Dementias, sponsored by Penn State University.
NCT05618834 is a NA study of Alzheimer Disease and Related Dementias that is active but no longer recruiting, run by Penn State University. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05618834, a NA study of Alzheimer Disease and Related Dementias, is active but no longer recruiting, sponsored by Penn State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of this study is to pilot test Promoting Positive Care Interactions (PPCI) with the goal of establishing a feasible and culturally responsive approach to optimize care interactions between staff (nursing, activity, housekeeping, and dining service staff) and residents with ADRD in assisted living facilities (ALFs), and further improve select resident, staff, and facility outcomes. PPCI is a non- pharmacological four-step approach consisting of (1) stakeholder engagement in developing facility specific goals; (2) environment and policy assessments; (3) flexible staff education; and (4) ongoing mentorship, motivation, and support (in-person visits and text messages) for staff to optimize care interactions.
Primary Outcome
4 items answered on a 5-point ordinal scale ranging from 'completely disagree' to 'completely agree'; range = 4 to 20 and higher scores are better
Conditions Studied
Interventions
- BEHAVIORAL Promoting Positive Care Interactions (PPCI)
- BEHAVIORAL PPCI-Staff Education Only (EO)
Study Locations (1)
Pennsylvania
- The Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What the registry record for NCT05618834 still lists
NCT05618834 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Alzheimer Disease and Related Dementias appearing as the primary indexed condition, and to 2 interventions - of which Promoting Positive Care Interactions (PPCI) is the first listed.
NCT05618834 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05618834 about?
NCT05618834 is a clinical study titled "Promoting Positive Care Interactions (PPCI) in Assisted Living". The overall aim of this study is to pilot test Promoting Positive Care Interactions (PPCI) with the goal of establishing a feasible and culturally responsive approach to optimize care interactions between staff (nursing, activity, housekeeping, and dining service staff) and residents with ADRD in as...
What is the current status of trial NCT05618834?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-03-03. Estimated completion is 2026-09-30.
What conditions does trial NCT05618834 study?
This clinical trial studies the following conditions: Alzheimer Disease and Related Dementias.
What interventions are being tested in trial NCT05618834?
The interventions under investigation include: Promoting Positive Care Interactions (PPCI) (BEHAVIORAL), PPCI-Staff Education Only (EO) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05618834?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05618834 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease and Related Dementias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05618834's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI